title: The efficacy and safety of sertaconazole cream (2 %) in diaper dermatitis candidiasis.
abstract: OBJECTIVE
  Diaper dermatitis (DD) is an inflammatory irritating condition that is common in infants. Most cases are associated with the yeast colonization of Candida or diaper dermatitis candidiasis (DDC), and therefore, the signs and symptoms improve with antimycotic treatment. Sertaconazole is a broad-spectrum third-generation imidazole derivative that is effective and safe for the treatment for superficial mycoses, such as tineas, candidiasis, and pityriasis versicolor. Our goal was to assess the efficacy and safety of sertaconazole cream (2 %) in DDC.
  
  
  METHODS
  Twenty-seven patients with clinical and mycological diagnosis of DDC were enrolled and treated with 2 daily applications for 14 days and were followed-up for 2 further weeks.
  
  
  RESULTS
  Three etiologic agents were isolated: Candida albicans in 88.8 %, Candida parapsilosis in 7.3 %, and Candida glabrata in 3.2 %. There was an average symptom reduction from 7.1 to 3.2 in the middle of treatment and to 1.2 and 0.4 units at the end of treatment and follow-up, respectively. The treatment evaluation at the end of the follow-up period showed a total clinical and mycological cure in 88.8 %, improvement in 3.7 %, and failure in 7.4 %. There was side effect (3.7 %) of skin irritation, but the drug was not discontinued.
  
  
  CONCLUSIONS
  Based on its safety and effectiveness, sertaconazole cream may be considered a new alternative for DDC treatment.
authors.affiliation: Department of Mycology, Hospital General de México OD, Mexico, DF, Mexico. a_bonifaz@yahoo.com.mx
authors.forename: Alexandro
authors.initials: A
authors.lastname: Bonifaz
authors.forename: Andrés
authors.initials: A
authors.lastname: Tirado-Sánchez
authors.forename: María José
authors.initials: MJ
authors.lastname: Graniel
authors.forename: Carlos
authors.initials: C
authors.lastname: Mena
authors.forename: Adriana
authors.initials: A
authors.lastname: Valencia
authors.forename: Rosa María
authors.initials: RM
authors.lastname: Ponce-Olivera
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002175:Candida / Q000145:classification / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D003963:Diaper Rash / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology / Q000473:pathology; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects*; D007223:Infant; D008297:Male; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D013876:Thiophenes; C061131:sertaconazole
references.citation: Folia Microbiol (Praha). 2003;48(3):385-8
references.pmid: 12879751
references.citation: Dermatology. 2003;206(2):136-41
references.pmid: 12592081
references.citation: Pediatr Dermatol. 1994 Mar;11(1):18-20
references.pmid: 8170842
references.citation: J Glob Infect Dis. 2011 Oct;3(4):357-60
references.pmid: 22223999
references.citation: Diagn Microbiol Infect Dis. 2006 Oct;56(2):147-52
references.pmid: 16822638
references.citation: Pediatr Dermatol. 1986 Feb;3(2):102-6
references.pmid: 3952026
references.citation: MCN Am J Matern Child Nurs. 2012 Jan-Feb;37(1):10-6
references.pmid: 22072018
references.citation: Pediatr Dermatol. 2001 Jul-Aug;18(4):282-90
references.pmid: 11576399
references.citation: J Drugs Dermatol. 2005 Jan-Feb;4(1):29-34
references.pmid: 15696982
references.citation: Mycoses. 2011 May;54(3):217-22
references.pmid: 19925567
references.citation: Curr Probl Dermatol. 2011;40:83-89
references.pmid: 21325842
references.citation: J Eur Acad Dermatol Venereol. 2010 Sep;24(9):1094-8
references.pmid: 20553355
references.citation: Pediatr Dermatol. 1986 Jun;3(3):198-207
references.pmid: 3523468
references.citation: Drugs. 2009;69(3):339-59
references.pmid: 19275277
references.citation: Hautarzt. 2011 Sep;62(9):699-708; quiz 709
references.pmid: 21882101
references.citation: An Bras Dermatol. 2009 Jan-Feb;84(1):47-54
references.pmid: 19377759
references.citation: Pediatr Dermatol. 1986 Feb;3(2):107-12
references.pmid: 3513143
references.citation: Pediatr Dermatol. 2001 Mar-Apr;18(2):149-55
references.pmid: 11358560
references.citation: Pediatr Clin North Am. 2000 Aug;47(4):909-19
references.pmid: 10943265
references.citation: Rev Med Liege. 2006 Apr;61(4):212-6
references.pmid: 16789605
references.citation: Int J Dermatol. 1992 Oct;31(10):700-2
references.pmid: 1399196
references.citation: Cutis. 1993 Sep;52(3):153-5
references.pmid: 8243098
references.citation: J Invest Dermatol. 2008 Feb;128(2):336-44
references.pmid: 17637821
references.citation: Dermatol Clin. 1999 Jan;17(1):235-40, x
references.pmid: 9987005
references.citation: Methods Find Exp Clin Pharmacol. 1996 May;18(4):233-4
references.pmid: 8803954